Evidence map›Paper›PMID 34441553›Full record

ReviewFoods (Basel, Switzerland)2021

Anti-Viral and Immunomodulatory Properties of Propolis: Chemical Diversity, Pharmacological Properties, Preclinical and Clinical Applications, and In Silico Potential against SARS-CoV-2.

Nermeen Yosri, Aida A Abd El-Wahed, Reem Ghonaim, Omar M Khattab, Aya Sabry, Mahmoud A A Ibrahim, Mahmoud F Moustafa, Zhiming Guo, Xiaobo Zou, Ahmed F M Algethami and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 93 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Antiviral and Anticancer Activities of Stingless Bee Propolis fromInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Ecological, Apicultural, and Therapeutic Value ofFoods (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 4 countries.

Nermeen YosriSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China.ORCID 0000-0002-5043-9690
Aida A Abd El-WahedDepartment of Bee Research, Plant Protection Research Institute, Agricultural Research Centre, Giza 12627, Egypt.ORCID 0000-0002-2200-3507
Reem GhonaimDepartment of Chemistry, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt.
Omar M KhattabDepartment of Chemistry, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt.
Aya SabryDepartment of Chemistry, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt.
Mahmoud A A IbrahimComputational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt.ORCID 0000-0003-4819-2040
Mahmoud F MoustafaDepartment of Biology, College of Science, King Khalid University, Abha 9004, Saudi Arabia.
Zhiming GuoSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China.ORCID 0000-0001-6416-7457
Xiaobo ZouSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China.
Ahmed F M AlgethamiAlnahalaljwal Foundation Saudi Arabia, P.O. Box 617, Al Jumum 21926, Saudi Arabia.
Saad H D MasryDepartment of Plant Protection and Biomolecular Diagnosis, Arid Lands Cultivation Research Institute (ALCRI), City of Scientific Research and Technological Applications, New Borg El-Arab City, Alexandria 21934, Egypt.
Mohamed F AlAjmiPharmacognosy Group, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Hanan S AfifiFood Research Section, R&D Division, Abu Dhabi Agriculture and Food Safety Authority (ADAFSA), Abu Dhabi P.O. Box 52150, United Arab Emirates.
Shaden A M KhalifaDepartment of Molecular Biosciences, Stockholm University, The Wenner-Gren Institute, SE-106 91 Stockholm, Sweden.
Hesham R El-SeediDepartment of Chemistry, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt.
Jiangsu University · CNMenoufia University · EGAgricultural Research Center · EGCity of Scientific Research and Technological Applications · EGKing Saud University · SAMinia University · EGSouth Valley University · EGStockholm University · SE

Funding

This work was supported by the Swedish Research Council Vetenskapsrådet VR grant 2016-05885
6 · The paper itself

Abstract

Propolis, a resin produced by honeybees, has long been used as a dietary supplement and folk remedy, and more recent preclinical investigations have demonstrated a large spectrum of potential therapeutic bioactivities, including antioxidant, antibacterial, anti-inflammatory, neuroprotective, immunomodulatory, anticancer, and antiviral properties. As an antiviral agent, propolis and various constituents have shown promising preclinical efficacy against adenoviruses, influenza viruses, respiratory tract viruses, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), human immunodeficiency virus (HIV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Over 300 chemical components have been identified in propolis, including terpenes, flavonoids, and phenolic acids, with the specific constituent profile varying widely according to geographic origin and regional flora. Propolis and its constituents have demonstrated potential efficacy against SARS-CoV-2 by modulating multiple pathogenic and antiviral pathways. Molecular docking studies have demonstrated high binding affinities of propolis derivatives to multiple SARS-CoV-2 proteins, including 3C-like protease (3CL

Indexed as

antiviralchemical constituentsclinical applicationsimmunomodulatorymolecular dockingpropolisSARS-CoV-2

Identifiers

PMID34441553
PMCPMC8391193
OpenAlexW3188074082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.